Explore the words cloud of the ZYMVOLVER project. It provides you a very rough idea of what is the project "ZYMVOLVER" about.
The following table provides information about the project.
ZYMVOL BIOMODELING SL
|Coordinator Country||Spain [ES]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2018-06-01 to 2018-09-30|
Take a look of project's partnership.
|1||ZYMVOL BIOMODELING SL||ES (LLEIDA)||coordinator||50˙000.00|
Actually, global enzymes market is today €8.18 billion and forecasted to reach €17.5 billion by 2024, so a sector growing at a CARG 9.56% in a 7-year projection. Europe is a main contender with over 62% of the exports. However, most companies with dedicated software for protein engineering computational are found in North America (46.0%), followed by Europe (29.4%), Asia-Pacific (17.9%) and RoW (6.7%). The production of daily life products such as paper, textiles, food, feed, chemicals and pharmaceuticals consumes large amounts of resources, water and energy. Furthermore, it generates enormous amounts of waste with an adverse impact on our environment and quality of life. Many studies show that implementing enzymatic processes instead of conventional chemical catalysis contributes to a more sustainable industry, reducing global warming (OECD, 2009; European Commission, 2009). ZYMVOLVER is a computer-driven speciality management to protein producers and industrial manufacturers. It offers a computer-aided decision-making tool for the adoption of industrial enzymes in standard industrial processes. We have developed a tool that will allow the democratization of computer-aided protein engineering. We offer a state-of-the-art, accessible, all-in-one computational tool that customize proteins with a 90% accuracy in terms of substrate selectivity, far beyond competition. ZYMEVOLVER - is exclusively owned by Zymvol. Our cloud-based, cost-effective software allows us to design any industrial enzyme from scratch, saving 50% of time and enzyme developing costs. The founding of Zymvol Biomodeling SL has over 20 years of combined experience previously working at one of Europe’s most important supercomputers – Barcelona Supercomputing Centre, which has been a necessary infrastructure for protein editing. ZYMVOL won the first prize in the pitch competition for most promising industrial start-up of 2017 organized by IQS Tech Factory and Richi Social Entrepreneurs in Boston.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ZYMVOLVER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ZYMVOLVER" are provided by the European Opendata Portal: CORDIS opendata.
MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINERead More
First anti-fraud plataform for the registration and certification of diplomas and academic certificates based in blockchainRead More
Pole climbing solution to improve safety at work and to prevent fatal accidents in industrial climbingRead More